Status: Recruiting
CytOSorb TreatMent Of Critically Ill PatientS Registry
Registry intended to provide a data repository and reporting infrastructure for the surveillance of CytoSorb device use in real-world critical care settings, and to serve as an objective, comprehensive, and scientifically-based resource to measure and improve the quality of patient care
Participants needed: 3,000
Trial details
Biological sex: AllType: ObservationalSponsor: CytoSorbents, IncUpdated: Sep 11, 2025Locations: 28Duration: 3 Months
Eligibility criteria
Planned OR actual CytoSorb® 300 mL device utilization [+1]
Use of the CytoSorb® 300 mL device for antithrombotic removal only [+2]